International Drug Monitoring: The Role of National Centres (WHO
Technical Report Series No. 498). Geneva: World Health Organization,
1972.
Lee A, Thomas SHL. Adverse drug reactions In: Walker R and Edward C.
Clinical pharmacy and Therapeutics. 3rd edition Churchill Livingstone
2003 33-46.
Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital
caused by adverse drug reactions: cross sectional incidence study.Br
Med J 2000; 320: 1036.
Wasserfallen J, Livio F, Buclin T, Tillet L, Yersin B, Biollaz J.
Rate, type and cost of adverse drug reactions in emergency department
admissions. Eur J Inter Med 2001; 12: 442–7.
Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug
events in hospitalised patients. Excess length of stay, extra costs,
and attributable mortality. JAMA 1997; 277: 301–6.
Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and
economic impact of adverse drug reactions in hospitalised patients.
Ann Pharmacother 2000; 34: 1373–9.
lassen DC, Pestotnik SL, Evans RS et al. Adverse drug events in
hospitalized patients. JAMA 1997; 277(4): 301-6.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions
in hospitalized patients: a meta-analysis of prospective studies. JAMA
1998; 279: 1200-5.
Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin
A, Kazemnejad A, Moin M. Adverse drug reactions in patients in an
Iranian department of internal medicine. Pharmacoepidemiol Drug Saf
2008 Dec 19 (Epub ahead of print).
Gholami K, Shalviri G. Factors associated with preventability,
predictability, and severity of adverse drug reactions. Ann
Pharmacother. 1999; 33(2):236-40.
Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring
in a secondary care hospital in South India. Br J ClinPharmacol 2008;
65(2): 210-6.
Al-Malaq HM, Al-Aqeel SA, Al-Sultan MS. Adverse drug reactions related
hospitalization identified by discharge ICD-9 codes in a univeristy
hospital in Riyadh. Saudi Med J. 2008 (8):1145-50.
Jha N, Bajracharya O, Namgyal T. Prevalence of adverse drug reactions
with commonly prescribed drugs in different hospitals of Kathmandu
valley. Kathmandu Univ Med J (KUMJ), 2007 Oct-Dec; 5(4):504-10.
Olsson S. The need for pharmacovigilance In: Gupta SK. Pharmacology
and therapeutics in the new millennium. Narosa publishing house, New
Delhi 2001 502-8.
WHO. Safety of medicines: A guide to detecting and reporting adverse
drug reactions. World Health Organization, Geneva, 2002.
Rawlins M. D.. Clinical pharmacology. Adverse reactions to drugs.
British medical journal (Clinical research ed.), 282, 974-976 1981
Hallit S, Hajj A, Shuhaiber P et al. Medication safety knowledge,
attitude, and practice among hospital pharmacists in Lebanon. Journal
of Evaluation in Clinical Practice 2019.25(2):323-39.
https://doi.org/10.1111/jep.13082
JSI Research & Training Institute, Inc. The KAP survey model, 2011.
https://www.spring-nutrition.org/publications/tool-summaries/kap-survey-model-knowledge-attitudes-and-practices
Aline Hajj, Souheil Hallit, Elsy Ramia, Pascale Salameh & on behalf
of the Order of Pharmacists Scientific Committee – Medication Safety
Subcommittee (2017): Medication safety knowledge, attitudes and
practices among community pharmacists in Lebanon, Current Medical
Research and Opinion, DOI: 10.1080/03007995.2017.1361916.
Kalaiselvan V, Prasad T, Singh A. Current Status of Adverse Drug
Reactions Monitoring Centres under Pharmacovigilance Programme of
India. Indian J Pharm Prac. 2014;7:19-22.
Murdaugh LB. Competence Assessment Tools for Health-System Pharmacies.
(4th ed), American Society of Health System Pharmacists, USA:
2007:439-40.
Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand:
implications for pharmacists. Ther Clin Risk Manag. 2005;1(3):181-8.
Parthasarathy G, Karin NH, Milap N. Clinic Pharmacy Book: Essential
Concepts and Skills. Hyderabad: Universities Press; 2008:43-53.
Bhagavathula AS, Elnour AA, Jamshed SQ. Health Professionals’
Knowledge, Attitudes and Practices about Pharmacovigilance in India: A
Systematic Review and Meta-Analysis. 2016 Jan;11(3):e0152221.
Ravinandan AP,Achutha V, Vikram K Ramani, Santosh Uttangi, Sushil
Kumar L. Study Of Knowledge, Attitude, And Practice Of Pharmacist
Towards Adverse Drug Reaction Reporting In Davangere City. Asian J
Pharm Clin Res, Vol 8, Issue 3, 2015, 262-265
Yu XM, Lee E,Koo BS, Jeong KH, Choi KH, Kang LK, et al. Predictive
Factors of Spontaneous Reporting of Adverse Drug Reactions among
Community Pharmacists. PloS one. 2016;11(5):e0155517.
Qassim S, Metwaly Z, Shamsain M, Al Hariri Y. Reporting adverse drug
reactions: Evaluation of knowledge, attitude and practice among
community pharmacists in UAE. IOSR J Pharm 2014;4(4):17-23.
Jose J, Jimmy B, Al-Ghailani AS, Al Majali MA. A cross sectional pilot
study on assessing the knowledge, attitude and behavior of community
pharmacists to adverse drug reaction related aspects in the Sultanate
of Oman. Saudi pharmaceutical journal : SPJ : the official publication
of the Saudi Pharmaceutical Society. 2014;22(2):163-9
Khalili H, Mohebbi N, Hendoiee N, Keshtkar AA, Dashti-Khavidaki S.
Improvement of knowledge, attitude and perception of healthcare
workers about ADR, a pre- and post-clinical pharmacists’
interventional study. BMJ open. 2012;2:e000367.
Su C, Ji H, Su Y. Hospital pharmacists’ knowledge and opinions
regarding adverse drug reaction reporting in Northern China.
Pharmacoepidemiology and drug safety. 2010;19(3):217-22.
Bawazir OA, Alsuwayt B, Alqahtani W, Al-Dhafiri A, Al-Shamrani M.
Knowledge, attitude and practice of pediatricians and pharmacists in
Riyadh City toward the use of sugar free medications. The journal of
contemporary dental practice. 2014;15(6):755-60.
Ravinder K. Sah, Rakhamaji D. Chandane, Krishna, Sachin Manocha, Ajita
Kapur. Knowledge, attitude and practice of pharmacovigilance among
community pharmacists in Delhi, India. International Journal of Basic
& Clinical Pharmacology | March 2017 | Vol 6
| Issue 3
Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M.
Influence of attitudes on pharmacists’ intention to report serious
adverse drug events to the Food and Drug Administration. British
journal of clinical pharmacology. 2011;72(1):143-52.
Sweis D, Wong IC. A survey on factors that could affect adverse drug
reaction reporting according to hospital pharmacists in Great Britain.
Drug safety. 2000;23(2):165-72.
Gavaza P, Brown CM, Lawson KA, Rascati KL, Steinhardt M, Wilson JP.
Pharmacist reporting of serious adverse drug events to the Food and
Drug Administration. Journal of the American Pharmacists Association :
JAPhA. 2012;52(5):e109-12.
Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M.
Texas pharmacists’ knowledge of reporting serious adverse drug events
to the Food and Drug Administration. Journal of the American
Pharmacists Association : JAPhA. 2011,51(3);397-403.
Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernandez-Diaz S,
Lasheras B. Factors that influence under-reporting of suspected
adverse drug reactions among community pharmacists in a Spanish
region. Drug safety. 2007;30(11):1073-82.
Ribeiro-Vaz I, Herdeiro MT, Polonia J, Figueiras A. Strategies to
increase the sensitivity of pharmacovigilance in Portugal. Revista de
saude publica. 2011;45(1):129-35.
Herdeiro MT, Polonia J, Gestal-Otero JJ, Figueiras A. Improving the
reporting of adverse drug reactions: a cluster-randomized trial among
pharmacists in Portugal. Drug safety. 2008;31(4):335-44.
Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ. An educational
intervention to improve physician reporting of adverse drug reactions:
a cluster-randomized controlled trial. Jama. 2006;296(9):1086-93.
Salim M. The Current Perspective of Community Pharmacists towards
Pharmacovigilance. J Pharmacovigil. 2015;3:180.
Suyagh M, Farah D, Farha RA. Pharmacist’s knowledge, practice and
attitudes toward pharmacovigilance and adverse drug reactions
reporting process. Saudi Pharmaceutical Journal. 2015;23:147-53.
Grootheest AC, Mes K, Van den berg LT, et al. Attitudes of community
pharmacists in the Netherlands towards adverse drug reaction
reporting. Int J Pharm Pract 2002;10(4):267-72.
Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of
suspected adverse
drug reactions: A review of published literature and international
experience. Br J Clin
Pharmacol 2007;63(2):148-56.
van Hunsel F, Passier A, van Grootheest K. Comparing patients’ and
healthcare professionals’ ADR reports after media attention: The
broadcast of a Dutch television programme about the benefits and risks
of statins as an example. Br J Clin Pharmacol 2009;67(5):558‑64.
Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK. An evaluation
of knowledge, attitude and practice of Indian pharmacists towards
adverse drug reaction reporting: A pilot study. Perspect Clin Res
2013;4(4):204-10.